Losartan reduces collagen content and intimal thickening of iliac arteries after balloon injury in rabbits

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 1, Issue 3, 2000, Pages 278-282

  Zhu, Jianhua ^a   Gao, Danchen ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Balloon injury; Collagen; Extracellular matrix; Intimal thickening; Losartan; Nonpeptide angiotensin II receptor antagonist; Stenosis

Indexed keywords

ANGIOTENSIN II; COLLAGEN; LOSARTAN;

ANIMAL; ARTICLE; BALLOON DILATATION; BLOOD; BLUNT TRAUMA; DRUG ANTAGONISM; DRUG EFFECT; ILIAC ARTERY; INJURY; INTIMA; MALE; METABOLISM; PATHOLOGY; RABBIT; TUNICA MEDIA;

ANGIOTENSIN II; ANIMALS; BALLOON DILATATION; COLLAGEN; ILIAC ARTERY; LOSARTAN; MALE; RABBITS; TUNICA INTIMA; TUNICA MEDIA; WOUNDS, NONPENETRATING;

EID: 0034286155     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2000.043     Document Type: Article

References (25)

1. Ming WL, Roubin GS, King S et al. Restenosis after coronary angioplasty:potential biologic determinants and role of intimal hyperplasia. 1989; 79(6): 1374-87.
2. Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983; 49: 208-15.
3. Strauss BH, Chisholm RJ, Keeley FW et al. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994; 75: 650-8.
4. Forester JS, Fishbein M, Helfant R et al. A Paradigm for restenosis based on cell biology: Clues for the development of new preventative therapies. J Am Coll Cardiol 1991; 17: 759-69.
5. Isner JM, Kearney M, Bortman S et al. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91: 2703-11.
6. Tardif JC, Cote G, Lesperance J et al. Probucol and multi-vitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997; 337: 365-72.
7. Lindner V, Fingerle J, Reidy MA. Mouse model of arterial injury. Circ Res 1993; 73: 792-6.
8. Olsen NE, Chao S, Lindner V et al. Intimai smooth muscle cell proliferation after balloon catheter injury:The role of basic fibroblast growth factor. Am J Pathol 1992; 140: 1017-23.
9. Mintz GS, Kovach JA, Pichard AD et al. Geometric remodeling is the predominant mechanism of clinical restenosis after coronary angioplasty. J Am Coll Cardiol 1994; 23: 138A.
10. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited:An alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992; 20: 1284-93.
11. 1-receptor antagonist: Effects in smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol 1991; 139(6): 1291-6.
12. Itoh H, Mukoyama M, Pratt RE et al. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993; 91: 2268.
13. Itoh H, Pratt RE, Gibbons G et al. Angiotensin II modulate proliferation of vascular smooth muscle cells via autocrine loops of TGF-beta and bFGF. Hypertension 1991;18:396.
14. Zhaoqiang C, Xi CH, Wenjiang CH et al. Relation of the transcription and regulation of type I angiotensin II receptor gene with myocardial remodeling in rats. Chin J Cardiol 1999;27(4): 307-10.
15. Suzuki J, Matsubara H, Urakami et al. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 1993;73: 439-47.
16. Raymond F, Kauffman, James S et al. Losartan, a nonpeptide angiotensin II receptor antagonist, inhibits neointimal formation following balloon injury to rat carotid arteries. Life Science 1991; 49: 223-8.
17. Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition, and formation of mural thrombi. Microvasc Res 1973; 5: 167.
18. Junquiere LCU, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochemical J 1979; 11: 447.
19. Hiroshi A, Yasunari N, Hidehisa H. Prevention of intimal thickening after endothelial removal by a nonpeptide angiotensin II receptor antagonist, Losartan. Br J Pharmacol 1992; 106: 665-71.
20. Yang SY, Hu ZY, Cao H et al. Effects of angiotensin II receptor antagonist on renin-angiotensin system in main organs of spontaneously hypertensive rats. Chinese Circulation J 2000; 15(1): 56-8.
21. Kenji M, Makio T Shigeatsu H et al. Effects of losartan, a nonpeptide angiotensin II receptor antagonist, on cardiac hypertrophy and the tissue angiotensin II content in spontaneously hypertensive rats. Life Science 1992; 51: pp: 367-74.
22. Miao LY, Jiang WP. Effects of valsartan on the angiotensin II levels and ventricular remodeling. Chin J Cardiol 1999; 27(6): 456-8.
23. Steckelings V, Levrum C. Role of brain angiotensin in cardiovascular regulation. J Cardiovas Pharmacol 1992; 19(Suppl 16): S73-9.
24. Caulfield M, Lavender P, Newell PJ et al. Angiotensinogen in human essential hypertension. Hypertension 1996; 28(6): 1123-5.
25. Eggena P, Barrett JD. Regulation and functional consequences of angiotensin gene expression. J Hypertens 1992; 10: 1063-8.